DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / A••••••• T••••••••• I•••
A••••••• T••••••••• I•••
Stage unknownIrvine, CABiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Mar 12, 2024Form D equity offering · $1.5M (form d sold) · 7 investorsFact SEC EDGAR Form D data sets (quarterly) · “A••••••• T••••••••• I••• filed Form D: $1,475,000 sold of $1,475,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
3 officers, 6 directors
- N••• H••••••••• Mr. H••••••••• serves as an executive officer of the company. sec.gov
- P••••• S••• Mr. S••• serves as an executive officer of the company. sec.gov
- S•••••• M•••••• Mr. M•••••• is the founder, chairman of the board and chief executive officer of the company. sec.gov
- R•• T••••• Mr. T••••• serves as a director of the company. Fact
- D•• D••••• Mr. D••••• serves a director of the company. Fact
- S••••• M•••• Mr. M•••• serves as a director of the company. Fact
- J••• W••• Mr. W••• serves as a director of the company. Fact
- M•••••• R••••• Mr. R••••• serves as a director of the company. Fact
- R•••• W•••••• Mr. W•••••• serves as a director of the company. Fact
Timeline
1
- Mar 26, 2024A••••••• T••••••••• I••• filed Form D: $1,475,000 sold of $1,475,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $1.5M Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $1.5M Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-03-12 Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 7 Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 25,000 Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 18001 Cowan, Suite L, IRVINE, CA, 92614 Mar 26, 2024 Fact SEC EDGAR Form D data sets (quarterly)